I am humbled and extremely grateful for the Best Mentor Award - lucky to have an awesome team pushing our brain tumor research forward @UFScripps ! Thank you!
In bio, what doesn't kill you mutates and tries again.
\
I recently sat down with @CurlyJungleJake and @DrNickGoldner to discuss how we address the root cause of resistance with TechBio platforms.
The best advice from our conversation: https://t.co/jJM04sCvkx
Wait until everyone freaking about the chatbots realize AI is curing cancer @resistanceBio, finding impossible antibodies at Abalone Bio and building DNA nano structures at Atom Bioworks.
@FertigLab @Bioconductor@Biopython Who specifically can we bring into the conversation to start getting these standards set? How do we make these standards, almost like clinical protocols? one of the fields biggest challenges would make data processing and clinician/regulatory buy in easier across the board
Cancer treatment resistance is an evolutionary game that can be understood and won, as long as we can learn the rules cancer plays by. Congrats to our SAB Chair @CancerConnector for learning more of cancers rules so that we can beat cancer at its own game!! #LATRcancer
Excited to share Theory Division's new publication in @ScienceAdvances detailing our observation of the ecological phenomenon competitive exclusion in #lungcancer cells. hats off to lead authors @NateFarrokhian + @JeffMaltas + team
A short #THREAD. 1/7
https://t.co/FArlJQG2Ey
Postdoc job alert: Interested in deciphering brain tumor ecosystem / developing in vivo models of GBM to study clonal interactions and tumor microenvironment / mapping spatial organization of cancer tissue? Join us! DM or email me to learn more. https://t.co/MVeVMgLpMx
Congratulation to @cncurtis for receiving the @AACR Award for Outstanding Achievement in Basic Cancer Research. Curtis is being honored for her paradigm-shifting research on tumor evolution. https://t.co/ewcTYzXF6W
Next Monday, April 11th, 5pm/8pm! Don't forget to join us in our discussion on Treatment-resistant cancer! Click on the link below to enter the chat room directly: https://t.co/ga0Bz4ctK5
Our live Twitter Space audio chat is just around the corner! In collaboration with some of our Advisory Board members @CancerConnector@n8pennell@janiszewska_lab, we will discuss the state of treatment resistance and our ideas for combating it. 🧬👇#cancerresearch#aacr22
Love this. Timescales are super important to consider - different mechanisms and strategies will play a role as they expand/contract. Ecology on short ones, evolution on longer ones. Maybe a nice perturbation problem for the more #mathonco inclined… #AACRevol22
@sesiegler@resistanceBio@CancerConnector@n8pennell @bulowcr @cncurtis @FertigLab @janiszewska_lab We plan to hold a monthly live Twitter space chat, first with our advisory board and then open up to experts in the field. You're very welcome to join us for the discussion on the 13th if you're available!
@sesiegler@resistanceBio@CancerConnector@n8pennell @bulowcr Hi Sara,
This will be the first of many Twitter chats with our advisory board, which includes equal representation of both male and female members. Unfortunately, @cncurtis and @FertigLab are unable to attend but @janiszewska_lab will join the chat, photo will be added!
How do two PhDs studying antibiotic resistance start a company hunting for irresistible #cancer therapies?
On this episode of Translation, we chat with @DrNickGoldner, co-founder and CEO of @resistanceBio, about his journey from bacteria to cancer.
🎙️: https://t.co/d1DcBwcS8r
Explore our new website and discover how we harness the power of evolution with our proprietary, first-of-its-kind ResCu platform to search and develop novel therapies to defeat treatment-resistant cancers! #evolution#precisionmedicine#cancer
https://t.co/sBGtA8QQcP
1/ 📢 Big Announcement 📢
Excited to reveal something I have been working on for a while. With help from @jamessinka and @shagun_mm
🔬 The On Deck DeepTech Fellowship (ODDT) 🔬
A continuous community for people to build or join revolutionary deep tech startups.